Paracetamol sustained release pellets were prepared using melt method.
采用熔融法制备了对乙酰氨基酚缓释微丸。
OBJECTIVE To select the coating fluid prescription of nefopam controlled release pellets.
目的筛选平痛新控释微丸包衣液处方。
The process included the preparation of prompt-release pellets and coating of the pellets.
制剂部分分为素丸的制备和包缓释衣膜。
But Roxithromycin sustained release pellets with smaller size show a better bioavailability.
但小粒径罗红霉素缓释微丸具有更高的生物利用度。
OBJECTIVE To prepare ribavirin sustained-release pellets by centrifugal granulation technology.
目的研究离心造粒粉末层积法制备利巴韦林缓释微丸。
Objective To prepare benproperine phosphate sustained-release pellets and study its release characteristics.
目的制备磷酸苯丙哌林缓释微丸，评价其体外释药特性。
Objective To prepare aciclovir sustained-release pellets and investigate the drug release mechanism in vitro.
目的制备阿昔洛韦缓释微丸，并对其体外释药情况进行研究。
In this thesis, Metformin Hydrochloride pellets and sustained-release pellets were prepared by powder coating technology.
本文采用流化床技术制备盐酸二甲双胍素丸，并采用缓释包衣材料制备缓释盐酸二甲双胍微丸。
METHODS To prepare sustained release pellets using fluid bed, then to get pulsatile-sustained tablet after tabletting and coating.
方法采用流化床包衣法制得缓释微丸，将微丸压片后包衣制得时控脉冲缓释片。
P. Conclusions Chitosan tripolyphosphate sodium could be used as a complex matrix material for sustained release pellets loading DS.
结论甲壳胺三聚磷酸钠可以作为双氯灭痛缓释微丸的骨架材料。
OBJECTIVE To study the dissolution profile of phosphate tetramethylpyrazine sustained release pellets coated with Eudragit pseudolatex.
目的研究磷酸川芎嗪丙烯酸树脂水分散体包衣缓释小丸的体外释药。
By in-liquid drying, sustained-release pellets were prepared taking Eurdragit RL100 as coating material and drug-resin complex as core.
以丙烯酸树脂RL 100为包衣材料，采用乳剂-溶剂挥发法，制备了以药物-树脂为丸芯的缓释微丸。
Objective: to investigate the factors involved in the release in vitro degree of terbutaline sulphate pulsatile controlled release pellets.
目的考察硫酸特布他林脉冲控释微丸释放度的影响因素。
Abstract: Response surface methodology was applied to optimize the drug loading rate of persimmon leaf total flavonoids sustained release pellets.
摘要：本文研究了响应面法优化柿叶总黄酮缓释微丸的载药量。
Objective To prepare pulsed-release capsule(PRC) using famotidine(FM) as a model drug and to explore the way of preparing pulsed-release pellets(PRP).
目的制备以法莫替丁为模型药物的脉冲控释胶囊；探索制备脉冲微丸的方法。
Conclusion This method is simple, rapid and accurate, which is suitable for the quality control of sinomenine hydrochloride sustained-release pellets.
结论该方法简便、准确、快速，可用于盐酸青藤碱缓释微丸的含量测定及质量控制。
By using membrane controlled-release technique and centrifugal coating pelletization, sinomenine hydrochloride controlled-release pellets were prepared.
采用膜控技术，离心包衣造粒法制备了盐酸青藤碱控释微丸。
OBJECTIVE To compare the influence of different pore-forming agents and their amount on the release of budesonide enteric-coated sustained-release pellets.
目的比较不同致孔剂及其用量对水难溶性药物布地奈德肠溶缓释微丸释药行为的影响。
Methods Membrane controlled-release technique and centrifugal coating pelletization were used to prepare sinomenine hydrochloride controlled release pellets.
方法采用膜控技术，离心造粒法制备盐酸青藤碱控释微丸。
Objective To prepare compound Danshen immediate-release pellets and obtain the synchronous release rate of components with significant difference of physicochemical properties.
目的制备复方丹参速释微丸，使理化性质差异较大的各成分达到同步释放。
In this paper, tetramethylpyrazine hydrochloride (TMPH), which is used for angina pectoris clinically, was selected as a water-soluble model drug to prepare timed release pellets.
本文选择临床上用于治疗心绞痛的药物盐酸川芎嗪(TMPH)作为水溶性模型药制备定时释药微丸。
The timed release pellets consist of 5 laminar layers from the center to the outside :the core, the drug layer, the swelling agent layer , the block layer and the controlled layer .
该脉冲微丸由5层结构组成，从内而外分别是丸芯、药物层、溶胀层、阻滞层和水不溶性控释层。
Conclusions The glipizide film-controlled sustained-release pellets were successfully prepared and the in-vitro drug release conformed to the requirements of the sustained-release formulation.
结论成功制备了膜控型格列吡嗪缓释微丸，体外释放符合缓释制剂要求。
Conclusions The glipizide film-controlled sustained-release pellets were successfully prepared and the in-vitro drug release conformed to the requirements of the sustained-release formulation.
结论成功制备了膜控型格列吡嗪缓释微丸，体外释放符合缓释制剂要求。
应用推荐